Pallas Capital Advisors LLC Biomarin Pharmaceutical Inc Transaction History
Pallas Capital Advisors LLC
- $2.43 Billion
- Q2 2025
A detailed history of Pallas Capital Advisors LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Pallas Capital Advisors LLC holds 28,518 shares of BMRN stock, worth $1.62 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
28,518
Previous 25,733
10.82%
Holding current value
$1.62 Million
Previous $1.82 Million
13.85%
% of portfolio
0.06%
Previous 0.08%
Shares
4 transactions
Others Institutions Holding BMRN
# of Institutions
674Shares Held
183MCall Options Held
1.23MPut Options Held
1.11M-
Black Rock Inc. New York, NY22.7MShares$1.29 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.08 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA15.8MShares$897 Million0.71% of portfolio
-
Dodge & Cox San Francisco, CA15.1MShares$859 Million0.5% of portfolio
-
Viking Global Investors LP12.3MShares$699 Million2.14% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $10.6B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...